Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating oral metronomic capecitabine in combination with pyrotinib for HER2-positive metastatic breast cancer that…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel [NA]
A clinical trial update indicates the study evaluating real-time pressure controllers to alleviate peripheral neuropathy symptoms in breast …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Effect of Laughter Therapy on Breast Cancer Patients [NA]
This entry notes a registered clinical trial to evaluate laughter therapy for psychological well-being in breast cancer patients, which is n…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study
A real-world study from Hebei Medical University Fourth Hospital evaluating neratinib as extended adjuvant therapy for patients with HER2-po…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers
This clinical trial update describes EpCAM-targeted Surface-Enhanced Raman Spectroscopy nanotags for rapid evaluation of surgical margins an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This update covers a completed Phase 1/2 clinical trial evaluating Tinengotinib (TT-00420) as both monotherapy and in combination therapy fo…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adherence to the Mediterranean Diet Among Women Attending Mammographic Screening
This clinical trial update describes a study evaluating adherence to the Mediterranean diet among women undergoing mammographic screening fo…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
This clinical trial update describes cascade genetic testing in families with newly diagnosed hereditary breast and ovarian cancer syndrome.…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Cognitive Training and Exercise for Women With Breast Cancer and Cognitive Impairment [NA]
A clinical trial evaluating cognitive training and exercise for women with breast cancer and cognitive impairment; currently not recruiting.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Real-world clinical trial update on sacituzumab govitecan as monotherapy or in combination for recurrent or metastatic HER2-negative breast …
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Early Intervention [NA]
A clinical trial update from Massachusetts General Hospital on early intervention for breast cancer and its treatment-related lymphedema. Th…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating a triple therapy of Pyrotinib, Dalpiciclib, and Letrozole for ER-positive, HER2-positive advanced bre…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating safety and efficacy of an antibody linked to chemotherapy for triple-negative metastatic breast cancer; trial is cu…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Early Diagnosis of Breast Cancer-related Lymphedema
This update describes a clinical trial investigating early diagnosis of breast cancer–related lymphedema. It is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery
ClinicalTrials.gov entry for a study on glutamate excitotoxicity in brain metastases from lung cancer, breast cancer, and melanoma treated w…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours [Phase 3]
This entry describes the Add-Aspirin Phase 3 trial evaluating whether adding aspirin after primary therapy reduces recurrence and improves s…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy
This update describes the rationale and study design for the PFB-03 trial evaluating 18F-FAPI-PET/CT for detecting axillary lymph node metas…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer [NA]
This clinical trial update outlines ongoing research into the mechanisms that explain differences in efficacy among neoadjuvant regimens for…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction [NA]
A clinical trial update from Washington University School of Medicine on using AI-assisted consultations (ChatGPT) to support breast reconst…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Assessment of Paclitaxel-Induced Neuropathy
This clinical trial update concerns assessment of paclitaxel-induced neuropathy in cancer patients, including breast and ovarian cancer, and…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: SABER Study for Selected Early Stage Breast Cancer [NA]
This clinical trial update reports that the SABER Study evaluating treatment for selected early-stage breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Arsenous Acid for Refractory Triple-Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial is investigating arsenous acid for refractory triple-negative breast cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection. [NA]
This clinical trial investigates nipple reconstruction in mastectomized patients using cross-linked hyaluronic acid injections and is curren…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study
This clinical trial update describes the BRAVE-Cyclin study, which is evaluating the incidence of venous thromboembolism and cardiovascular …